A multicountry user experience analysis of e-TB Manager and an in-depth study in Ukraine were published. However, the procedural aspects of e-TB Manager implementation in each country were not documented. While facilitators and barriers for eHealth implementation in resource-constrained settings are well known, the objective of this paper is to summarize the tailored implementation approaches given local context, which is a crucial consideration. The paper summarizes the key lessons learned and implications for other electronic health information systems.
User experience analysis of an eHealth system for tuberculosis in resource-constrained settings: A nine-country comparison
Konduri N, Bastos LGV, Sawyer K, Reciolino LFA. User experience analysis of an eHealth system for tuberculosis in resource-constrained settings: A nine-country comparison. International Journal of Medical Informatics 102 2017; 118-29.
Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected review
Konduri N, Rauscher M. Shio-Chu JW, Malpica-Llanos T. Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected review. Journal of Pharmaceutical Policy and Practice 2017;10:16.
User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine
Konduri N, Sawyer K, Nizova N. User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine. European Respiratory Journal Open Research 3;2017: 00002-2017.
Konduri N, Delmotte E, Rutta E. Engagement of the private pharmaceutical sector for TB control: Rhetoric or reality? Journal: Journal of Pharmaceutical Policy and Practice, 2017, Volume 10, Number 1
Konduri N, Lebega O. Analysis of medicines expenditure in ukraine: Implications for rational selection. E9 Short oral presentation, Part 2a (Practice & Education) at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016, Buenos Aires, Argentina. August 30, 2016.
How Public Funds Were Spent on Procurement of Medicines in Ukraine’s Hospitals: Interim Analysis for the Ministry of Health, Ukraine
Pharmaceuticals may constitute as much as 40% of the health care budget in low and middle-income countries, yet large portions of the population may lack access to even the most essential medicines. The limited public sector funds are frequently spent on ineffective or unnecessary medications. An analysis of past spending patterns on procurement of medicines will help the Ministry of Health policymakers and key government stakeholders in Ukraine for decisions on adopting the national Essential Medicines List (EML) in practice.
The purpose of this technical brief is twofold:
- To demonstrate the need to rationalize limited public funds for maximum health impact.
- To emphasize the need for proper selection of medicines based on WHO recommendations and the rationale for an EML as the sole basis for public sector procurement in Ukraine.
After summarizing high-level data analysis, this technical brief also takes a close look at insulins and analogues that account for the most expenditure.
This [report] is extremely useful. We need to use this information for the purpose of reforming the procurement system as well. The EML has become even more necessary now.”
– Dr. Ihor Perehinets, Deputy Minister of Health of Ukraine
A comprehensive assessment of DPM’s medicine regulatory system was conducted September to October 2017 by SIAPS funded by USAID. The […]
A presentation by Kwesi Eghan, Principal Technical Advisor, on March 19, 2018.
According to the World Health Organization, many countries spend 30–40% of their health care budgets on medicines and medical commodities, […]